## **Core Concept**
The question tests knowledge of anesthetic agents, specifically those used for induction, and their implications in patients with asthma. Asthma is a chronic inflammatory disease of the airways characterized by recurring episodes of reversible airflow obstruction. The ideal anesthetic agent in asthma should not trigger bronchospasm.

## **Why the Correct Answer is Right**
Ketamine is known for its bronchodilatory properties, making it a favorable choice in patients with asthma. It works by increasing the levels of catecholamines in the body, which helps in relaxing the bronchial smooth muscles. However, among the given options, the correct answer is related to an agent that can provoke bronchospasm.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Ketamine is actually beneficial in asthma due to its bronchodilatory effects.
* **Option B:** Propofol is generally considered safe in asthma as it has a low potential for causing histamine release, which can lead to bronchospasm.
* **Option D:** Midazolam, a benzodiazepine, is not typically known for inducing significant bronchospasm and can be used cautiously in patients with asthma.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that etomidate and propofol are often considered safer in patients with asthma or chronic obstructive pulmonary disease (COPD) compared to other induction agents that might cause more histamine release or direct bronchoconstriction. Specifically, **thiopental (Option C)** can cause histamine release, leading to potential bronchospasm in susceptible individuals like those with asthma.

## **Correct Answer: C. Thiopental.**